79 filings
Page 3 of 4
8-K
czqe a0mav4qy61
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am
8-K
iug5r0zwno77ggmoz2i
28 Jan 21
Other Events
8:11am
8-K
b8jyet1v
27 Jan 21
Other Events
4:11pm
8-K
tciv h6eddo4l8
12 Nov 20
PhaseBio Reports Recent Business Highlights and Third-Quarter 2020 Financial Results
4:12pm
8-K
9q7vb
23 Oct 20
PhaseBio Provides Pemziviptadil (PB1046) Program Update
8:20am
8-K
0m5qdu51wtfm83
6 Oct 20
Other Events
8:09am
8-K
01qmi
11 Aug 20
PhaseBio Reports Recent Business Highlights and Second-Quarter 2020 Financial Results
4:09pm
8-K
g8csn95
16 Jul 20
Other Events
4:10pm
8-K
k45 0q6rarnqf1pw
5 Jun 20
Submission of Matters to a Vote of Security Holders
4:36pm
8-K
7q0e0 pza
27 May 20
PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients
4:11pm
8-K
g5j 99vt7
12 May 20
PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights
4:08pm
8-K
4ap5p s5g
30 Mar 20
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
8:08am
8-K
m2dk7z4
20 Mar 20
Entry into a Material Definitive Agreement
4:13pm
8-K
t7cm2s
4 Mar 20
Regulation FD Disclosure
4:06pm
8-K
ei1av6
13 Feb 20
PhaseBio Appoints Alex C. Sapir to Board of Directors
4:07pm
8-K
k84cdr6o
11 Feb 20
PhaseBio Announces European Regulatory Update for PB2452
8:08am
8-K
imrdottgk g4k
4 Feb 20
PhaseBio Announces Case Study Highlighting PB1046 Hemodynamic Data Presented at 14th Pulmonary Vascular Research Institute World Congress
4:08pm
8-K
rhka7f7u b8m2jzi2xu
13 Jan 20
PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor to Develop for Treatment-Resistant Hypertension
4:07pm
8-K
70b5yxn65g2gqjplb
10 Jan 20
PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals® for PB2452
9:07am
8-K
flsp29lj
14 Nov 19
PhaseBio Reports Third Quarter 2019 Financial Results and Recent Corporate Progress
8:16am